WebDisclosure WebDisclosure
Basculer en Français
9560 Companies
188851 Keywords
120589 Articles
100789 Press releases
Headlines Articles Press releases AmeboGenesis, LLC Remove
  1. Home
  2. Companies
  3. AmeboGenesis, LLC
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/26/2024 at 12:20, 1 year 8 months ago

    Groundbreaking Biomedical Innovation: AmeboGenesis Unveils Eco-friendly Amebocyte Production for LAL Tests

    Sustainable Production AmeboGenesis Biomedical Testing LAL Testing Biotechnology Innovation
  • BRIEF

    published on 03/26/2024 at 12:20, 1 year 8 months ago

    Innovation biomédicale révolutionnaire : AmeboGenesis dévoile une production écologique d'amibocytes pour les tests LAL

    Production Durable AmeboGenèse Tests Biomédicaux Test LAL Innovation En Biotechnologie
  • PRESS RELEASE

    published on 03/26/2024 at 12:15, 1 year 8 months ago

    A Revolutionary Breakthrough in Biomedical Testing: AmeboGenesis Introduces Sustainable Amebocyte Production for LAL Testing to Detect Bacterial Contamination

    AmeboGenesis™ introduces sustainable Amebocyte production technology eliminating the need for horseshoe crab blood harvesting. The innovative method promises reliable LAL source for endotoxin testing
    Biotechnology Sustainable Production AmeboGenesis LAL Testing Amebocyte
    Logo of AmeboGenesis, LLC
Accesswire
  • Published on 12/20/2025 at 00:30, 1 day 21 hours ago

    Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025

  • Published on 12/19/2025 at 22:00, 1 day 23 hours ago

    GMV Minerals Inc. Closes Non-Brokered Equity Financing

  • Published on 12/19/2025 at 18:30, 2 days 3 hours ago

    Eagle Plains Shareholders Approve all Matters at Annual General Meeting

  • Published on 12/19/2025 at 14:40, 2 days 7 hours ago

    Northern Superior Announces Closing of the Arrangement

  • Published on 12/19/2025 at 13:30, 2 days 8 hours ago

    Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE
EQS Group
  • Published on 12/21/2025 at 08:55, 12 hours 44 minutes ago

    Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro

  • Published on 12/20/2025 at 16:45, 1 day 4 hours ago

    Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade

  • Published on 12/20/2025 at 10:05, 1 day 11 hours ago

    FITUR 2026 highlights the strong synergies between Germany and Spain

  • Published on 12/19/2025 at 22:03, 1 day 23 hours ago

    EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector

  • Published on 12/19/2025 at 21:40, 1 day 23 hours ago

    IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries

View all EQS
Les Echos
  • Published on 12/19/2025 at 21:57, 1 day 23 hours ago

    Mise à disposition du document d’enregistrement universel

  • Published on 12/19/2025 at 08:30, 2 days 13 hours ago

    Share capital decrease by way of treasury shares cancellation

  • Published on 12/19/2025 at 08:30, 2 days 13 hours ago

    Réduction du capital par voie d’annulation d’actions propres

  • Published on 12/19/2025 at 07:00, 2 days 14 hours ago

    EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS

  • Published on 12/19/2025 at 07:00, 2 days 14 hours ago

    EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy